Beruflich Dokumente
Kultur Dokumente
PolarHeadGroups
Threecarbonglycerol
What is a liposome?
Spherical vesicles with a phospholipid bilayer
Hydrophilic
Hydrophobic
Cell Membrane
Uses of Liposomes
Chelation therapy for treatment of heavy metal
poisoning
Enzyme replacement
Diagnostic imaging of tumors
Cosmetics
Study of membranes
Drug Delivery
Protection
Decrease harmful side effects
Changewheredrugaccumulatesinthebody
Protectsdrug
Modes of Liposome/Cell
Interaction
Adsorption
Endocytosis
Fusion
Lipid
transfer
Classes of Liposomes
Conventional
Long circulating
Immuno
Cationic
Custom design
Lipid content
Size
Surface charge
Method of preparation
Examples
Duanorubicin, Doxorubicin*,Epirubicin
Methotrexate,Cisplatin*,Cytarabin
Triclosan,Clindamycinhydrochloride,
Ampicillin,peperacillin,rifamicin
AZT
cDNACFTR*
HexosaminidaseA
Glucocerebrosidase,Peroxidase
In111*,Tc99m
AmphotericinB*
Malariamerozoite,Malariasporozoite
HepatitisBantigen,Rabiesvirusglycoprotein
*CurrentlyinClinicalTrialsorApprovedforClinicalUse
LiposomalFormulationofAmB
Phospholipid:AmBratio
AmB
Cholesterolonlyfew%moles
Lipid
ExactMechanismofliposomesnotunderstood
Diffusion
Lipidtransfer
Decreaseintoxicity
Nodecreaseineffectivenessofdrugagainstfungi
Lacklongtermstability(shortshelflife)
Physicalandchemicalinstability
FreezedryandpHadjustment
LowPayLoadpoorencapsulation
Polardrugsanddrugswithoutoppositecharge
Modifications
Problemscontinued
Possibilityofnewsideeffects
Doxilhandandfootsyndrome
Efficacy
CFTR
Future
Studieswithinsulinshowthatliposomesmay
beaneffectivewaytopackageproteins
andpeptidesforuse
ClinicalTrialsforseveralliposomalformulations
Morestudiesonthemanipulationofliposomes
Journals
Allen,TheresaM."LiposomalDrugFormulations:RationaleforDevelopmentandWhatWeCan
ExpectfortheFuture."Drugs56:747756,1998.
Allen,TheresaM."Longcirculating(stericallystabilized)liposomesfortargeteddrugdelivery."
TiPs15:214219,1994.
Allen,TheresaM."OpportunitiesinDrugDelivery."Drugs54Suppl.4:814,1997
Janknegt,Robert."LiposomalandLipidFormulationsofAmphotericinB."ClinicalPharmacokinetics.
23(4):279291,1992.
Kim,Annaetal."Pharmacodynamicsofinsulininpolyethyleneglycolcoatedliposomes."
InternationalJournalofPharmaceutics.180:7581,1999.
Quilitz,Rod."OncologyPharmacotherapy:TheUseofLipidFormulationsofAmphotericinBinCancer
Patients."CancerControl.5:439449,1998.
Ranade,VasantV."DrugDeliverySystems:SiteSpecificDrugDeliveryUsingLiposomesasCarriers."
Pharmacology.29:685694,1989.
Storm,GertandDaanJ.A.Crommelin."Liposomes:quovadi?"PSTT1:1931,1998.
Taylor,KMGandJMNewton."Liposomesasaveciclefordrugdelivery."BritishJournalofHospital
Medicine.51:5559,1994
Websites
James,JohnS."DoxilApprovedforKS."www.immunet.org.imminet/atn.nsf/page/a23503.
Wasan,Ellen."TargetedGeneTransfer."Member.tripod.com/~rrishna/lipos1.html
"IntroductiontoControlledDrugDeliverySystems."www5.bae.ncsu.edu/bae/reearch/blak
k/otherprojects/drugDeliver_97/
http://www.Mssm.edu/medicine/thrombosis/phosphol.html
"Doxorubicin."http://tirgan.com/adria.htm
"ClinicalPharmacologyOnline."http://www.cponline.gsm.com/scripts/fullmono/showmono.
"Drugstore.com"http://www.drugstore.com/pharmacy/prices/Amphotec.
"Sequus'DoxilBecomesFirstLiposomeProductApprovedInU.S."www.slip.net/~mcdavis/
database/doxor_1
"Liposomes."www.collabo.com/liposom0.htm
Paustin, Timothy. Cellular Membranes.www.bact.wisc.edu/microtextbook/bacterialstructure/Membranegen.html
www.cbc.umn.edu/~mwd/cell_www/chapter2/membrane.html#PHOSPHOLIPIDS
Books
Jones,MacolmN.andChapman,David.Micelles,MonolayersandBiomembranes.WileyLiss.
NewYork(1995).
Garrett,R.andGrishamC.Biochemistry,2nded.SaundersCollegesPublishing.NewYork(1999).264.